Cardio Diagnostics
CDIO | NASDAQ
$1.79
-$0.10 (-5.29%)
At close: Nov 16, 2026, 4:00 PM ET
$1.82
+$0.03 (+1.68%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-5.29%
(1D)No price chart data available for 1D timeframe.
Rating
34.2
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #675/1021 (Top 66%)
Key Statistics
Market Data
Market Cap $5.3M
1D Range
1.76 1.96
52W Range
1.05 6.55
Valuation (TTM)
PE -0.71
PB 0.93
EV/EBITDA -0.26
Valuation (NTM)
Forward PE N/A
Forward PEG -0.01
Price Target $0.00
Cash Flow
FCF Yield -109.5%
SBC Adj. FCF Yield -111.3%
SBC Impact -1.7%
Margins
Gross Margin -523.3%
Operating Margin -42649.8%
FCF Margin -38202.9%
Growth (CAGR)
Revenue 3Y | 5Y 6.1% |
19.7%
Dil EPS 3Y | 5Y 59.8% |
-22.7%
FCF 3Y | 5Y 2.0% |
-6.4%
Returns
ROA -106.6%
ROE -89.4%
ROIC -108.7%
Financial Health
Net Cash
$3.7M
Current Ratio 17.44
Interest Coverage -564.93
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Cardio Diagnostics Holdings, Inc. specializes in creating and bringing to market advanced clinical diagnostic tools that leverage epigenetic insights to address cardiovascular disease. Among their key...
Sector Healthcare
Industry Biotechnology
Employees 15
IPO Date Jan 14, 2022
Website www.cdio.ai
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove CDIO